Seagen (NASDAQ:SGEN) Earns Hold Rating from Analysts at began coverage on shares of Seagen (NASDAQ:SGEN – Free Report) in a report released on Thursday. The brokerage issued a hold rating on the biotechnology company’s stock. Several other brokerages have also commented on SGEN. Morgan Stanley reaffirmed an equal weight rating and issued a $229.00 price target on shares of Seagen in a […]

Leave a Reply

Your email address will not be published.

Previous post Okta, Inc. (NASDAQ:OKTA) Receives $91.03 Consensus PT from Brokerages
Next post Morgan Stanley Increases TFI International (NYSE:TFII) Price Target to $164.00